查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1675397

2025 年至 2033 年单核苷酸多态性基因分型市场报告（按技术、应用和地区）

Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球单核苷酸多态性 (SNP) 基因分型市场规模达到 113 亿美元。 展望未来， IMARC Group预计到 2033 年市场规模将达到 423 亿美元，2025-2033 年期间的成长率 (CAGR) 为 15.00%。不断增长的基因型研究和开发活动、对个人化医疗和新型药物输送系统的需求不断增长、以及对动物和植物原料的基因分析的需求不断增长是推动市场发展的一些关键因素。

单核苷酸多态性 (SNP) 基因分型是一种透过检查个体脱氧核糖核酸 (DNA) 序列内的特定位置来识别和分析个体间遗传变异的技术。它涉及确定个体 DNA 中特定 SNP 位点上存在的特定核苷酸。它依赖先进的分子生物学技术，例如聚合酶炼式反应（PCR）和 DNA 定序，其中 PCR 扩增包含 SNP 的 DNA 片段，然后透过直接对扩增的 DNA 进行定序或使用其他方法（如微阵列或等位基因特异性 PCR）来确定 SNP 位点的核苷酸。它有助于了解群体遗传学、迁移模式和演化历史。它在确定药物反应、预测疾病易感性以及根据特定基因特征制定治疗方案方面发挥着至关重要的作用。研究人员利用 SNP 基因分型来研究复杂疾病的遗传基础、识别遗传风险因子并开发增强的诊断工具。

单核苷酸多态性（SNP）基因分型市场趋势：

目前，随着基因型研发活动的增加以及生物资讯学在各类疾病的诊断工具或有效治疗方法的开发中的应用，对 SNP 基因分型的需求不断增加，是支持市场成长的关键因素之一。此外，SNP 基因分型在癌症、心血管疾病、阿兹海默症和气喘等各种人类疾病病因学中的应用越来越广泛，这也提供了良好的市场前景。除此之外，对于 SNP 基因分型的需求也在增加，以建立遗传关係、解决亲子关係纠纷以及协助世界各地的刑事调查。这一点，加上蓬勃发展的医疗产业，正在推动市场的成长。此外，由于个人化医疗和新型药物输送系统的不断增加，对药物基因组学的需求不断增加，从而增强了市场的成长。除此之外，农业生物技术、诊断研究、製药、药物基因组学以及动物和牲畜育种等生命科学领域的众多 SNP 基因分型技术正在促进市场的成长。同时，全球糖尿病、心血管疾病和癌症的发生率不断上升，对市场产生了正面影响。此外，对动物和植物原料基因分析的需求不断增长，推动了市场的成长。

本报告回答的关键问题：

  • 全球单核苷酸多态性（SNP）基因分型市场迄今表现如何，未来几年将如何表现？
  • 全球单核苷酸多态性 (SNP) 基因分型市场有哪些驱动因素、限制因素和机会？
  • 每个驱动因素、限制因素和机会对全球单核苷酸多态性 (SNP) 基因分型市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家拥有最具吸引力的单核苷酸多态性（SNP）基因分型市场？
  • 基于科技的市场分化是怎样的？
  • 单核苷酸多态性（SNP）基因分型市场中哪种技术最具吸引力？
  • 根据应用，市场区隔是怎样的？
  • 单核苷酸多态性（SNP）基因分型市场中最具吸引力的应用是什么？
  • 全球单核苷酸多态性（SNP）基因分型市场的竞争结构是怎么样的？
  • 全球单核苷酸多态性（SNP）基因分型市场的主要参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球单核苷酸多态性 (SNP) 基因分型市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场区隔：依技术

  • TaqMan SNP 基因分型
  • Massarray SNP 基因分型
  • SNP 基因晶片阵列
  • 其他的

第七章：市场区隔：依应用

  • 动物遗传学
  • 工厂改进
  • 诊断研究
  • 製药和药物基因组学
  • 农业生物技术
  • 其他的

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：驱动因素、限制因素与机会

  • 概述
  • 驱动程式
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Eurofins Genomics (Eurofins Scientific SE)
    • Illumina Inc.
    • Integrated DNA Technologies, Inc. (Danaher Corporation)
    • LGC Limited
    • PREMIER Biosoft
    • Promega Corporation
    • QIAGEN NV
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A8146

The global single nucleotide polymorphism (SNP) genotyping market size reached USD 11.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.3 Billion by 2033, exhibiting a growth rate (CAGR) of 15.00% during 2025-2033. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:

Technology Insights:

  • TaqMan SNP Genotyping
  • Massarray SNP Genotyping
  • SNP GeneChip Arrays
  • Others

Application Insights:

  • Animal Genetics
  • Plant Improvement
  • Diagnostic Research
  • Pharmaceuticals and Pharmacogenomics
  • Agricultural Biotechnology
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc. (Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
  • What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
  • What are the key regional markets?
  • Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
  • Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 TaqMan SNP Genotyping
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Massarray SNP Genotyping
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 SNP GeneChip Arrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Animal Genetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plant Improvement
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceuticals and Pharmacogenomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Agricultural Biotechnology
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eurofins Genomics (Eurofins Scientific SE)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Illumina Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 LGC Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 PREMIER Biosoft
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Promega Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 QIAGEN N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Roche Holding AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2024
  • Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
  • Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Competitive Structure
  • Table 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Players